FVIII concentrate

DRUG2 trials

Sponsors

The University of Texas Health Science Center, Houston, Federico II University

Conditions

Hemophilia A

Phase 4

Intensive Replacement Treatment in Haemophilia Patients With Synovitis

CompletedNCT04784988

Federico II UniversityHemophilia A

Start: 2022-03-01End: 2024-03-01Updated: 2024-03-27

Unknown Phase

Hemophilia Inhibitor Previously Untreated Patient Study

CompletedNCT01652027

The University of Texas Health Science Center, HoustonHemophilia A

Start: 2011-07-31End: 2020-03-31Updated: 2020-11-10

Related Papers

Prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures during FVIII inhibitor eradication

Blood Advances2022-09-084 citations

The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development

Blood Advances2020-11-2433 citations

Data Coming out of the Human Inhibitor PUP Study (HIPS) Reveal 4 Subgroups of Patients with Distinct Antibody Signatures

Blood2018-11-293 citations

Longitudinal Antibody Signatures Following FVIII Replacement Therapy in Previously Untreated Patients with Severe Hemophilia Α- New Insights from the Hemophilia Inhibitor PUP Study (HIPS)

Blood2017-12-07

Appearance of High-Affinity Antibodies Precedes Clinical Diagnosis of FVIII Inhibitors - Preliminary Analysis from the Hemophilia Inhibitor PUP Study (HIPS)

Blood2016-12-023 citations